Mercer Global Advisors
INBX icon

Mercer Global Advisors’s Inhibrx INBX Stock Holding History

Mercer Global Advisors’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.3K Buy
+404
New +$40.5K ﹤0.01% 4469

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Mercer Global Advisors's INBX Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Inhibrx (INBX) in Q2 2026: 404 shares worth $38.3K. The stake represents ﹤0.01% of the portfolio and ranks #4469 among its holdings.

148 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Mercer Global Advisors held 404 shares of Inhibrx worth $38.3K as of Q2 2026.
  • Inhibrx was a new Mercer Global Advisors position in Q2 2026.
  • Inhibrx made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4469 holding.
  • 148 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.